"In our clinical trials, Cagrilintide has provided substantial weight loss, in a distinct manner compared to approved obesity medications, and appears well-tolerated," Martin Holst Lange, Novo Nordisk's chief scientific officer and executive vice president of research and development, said in a statement
Kersthold M, et al
But whenever Sinclair brings up senolytics, he usually mentions both fisetin and quercetin, both of which are potent anti-inflammatory plant-based compounds (polyphenols) that significantly reduce senescent cells in preclinical studies
This is because your brain and body rely on glucose for energy, and when it drops too low, it triggers a stress response that includes nausea
It is not a licensed medicine and is supplied strictly for laboratory research purposes is not approved for human consumption, and must not be used in any clinical, therapeutic, cosmetic, or diagnostic context, regardless of its natural origin or its documented activity in laboratory research models
